Purchase Order HHSN272201700322P

This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for gene synthesis, expression, and purification services valued at $11,211.10. The contract was awarded by the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) and does not have a set-aside designation. The contract supports the production of recombinant mouse monoclonal IgE antibodies that can recognize and distinguish between nut allergens Ana o 3 and Car i 1....

Genscript USA Inc. was awarded a $54,900 firm-fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide customized antibody and plasmid preparation services. The award is associated with a pre-solicitation notice indicating the NIAID's intent to negotiate on a sole-source basis with Genscript for 100 customized antibodies and 200 plasmid preparations to support identification of...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $3,800.00, is for custom monoclonal antibody production services to support NIAID's biomedical research and public health initiatives. This contract does not have a set-aside designation. Genscript...

This is a firm fixed-price purchase order awarded by the U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS) Midwest Area to Envigo Bioproducts Inc. for $22,655.00. The contract is for hybridoma services across three stages: Stage 1 - hybridoma services for 3 immunogens and 10 Balb/C mice; Stage 2 - fusion and subcloning services (option); and Stage 3 - cloning and small-scale antibody production (option). The contract has an ultimate completion date of May 31, 2025. Envigo...

This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $96,751.91 contract is for the provision of custom antigens to support assay development work. The award has no set-aside designation. Genscript specializes in supplying a range of molecular biology products and services to various federal agencies, including the Department of Health and Human Services. The...

This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for the delivery of custom rabbit monoclonal antibodies to support the development of diagnostic tests for taeniasis and cysticercosis. The award, valued at $49,981.00, was made by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia and has a period of performance from September 30, 2024 to April 22, 2025. The original solicitation, a Request for Quotations (RFQ), was...

This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...

The Centers for Disease Control and Prevention awarded Abcellera Biologics Inc. a definitive fixed price contract valued at $884,000 to provide a transgenic mouse model capable of generating humanized antibodies against influenza viruses. The original solicitation sought proposals for a mouse engineered with human immunoglobulin gene segments to better recapitulate the human antibody repertoire when testing candidate virus strains and developing antibodies. Under the contract, Abcellera will...

This contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, provides Genscript USA Inc. with $137,250.00 to deliver monoclonal antibodies and plasmid services. The firm-fixed price purchase order has an ultimate completion date of August 31, 2025. Genscript USA Inc. is a biotechnology company in Piscataway, New Jersey that specializes in molecular biology products and services for federal agencies....

This firm fixed-price purchase order for approximately $54,700 was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Sino Biological US Inc. to support antiviral drug development efforts. Under the contract, Sino Biological will generate hybridoma cell lines and monoclonal antibodies targeting four viral proteins of priority pathogens identified by the Antimicrobial Resistance Coordination and Strategy Unit. The work includes providing...